Showing results (1491-1500 of 6,130) with videos related to

Sort By:
Pageof 613
International Journal of Antimicrobial Agents|August 10, 2026
Impact of an Antimicrobial Stewardship intervention on clinical and economic outcomes in Outpatient Parenteral Antimicrobial Therapy (OPAT) for urinary tract infections: a quasi-experimental studySilvia Gómez-Zorrilla, Rosa Ana Sabaté, Inmaculada López Montesinos, et al.
International Journal of Antimicrobial Agents|July 29, 2026
Pharmacogenomic Variability in Adolescents and Youth with Virologic Rebound While Receiving Injectable Cabotegravir/Rilpivirine: A Multi-case SeriesTimothy J Howze, Susan D Carr, Nehali D Patel
International Journal of Antimicrobial Agents|August 7, 2026
Association between tazobactam-piperacillin exposure and the subsequent emergence in gram-negative rods: Findings from a single-institution cohort studyEzaki Masayoshi, Kato Noriko, Nagaoka Kentaro, et al.
International Journal of Antimicrobial Agents|July 29, 2026
Antimicrobial prophylaxis regimens in joint replacement surgery: susceptibility and PK/PD target attainmentAlba Rivera, Sonia Luque, Isabel Mur, et al.
International Journal of Antimicrobial Agents|August 28, 2026
Proteomics reveals the mechanism by which sodium oleate decreases Escherichia coli susceptibility to gentamicinLvyuan Fan, Jingyun Wu, Ziyi Zhang, et al.
International Journal of Antimicrobial Agents|August 28, 2026
Evaluation of Vancomycin Bolus/Standard and Continuous Infusion on Nephrotoxicity in a Rat ModelSylwia Marianski, Gwendolyn M Pais, Colin Jeantet, et al.
International Journal of Antimicrobial Agents|August 27, 2026
Host Inflammation Drives Low-Exposure Nephrotoxicity in Critically Ill Patients Receiving Polymyxin B: A Prospective StudyXuemei Luo, Dayu Chen, Huaijun Zhu, et al.
International Journal of Antimicrobial Agents|August 31, 2026
Global burden of bacterial antimicrobial resistance among children under five years 1990-2021: a systematic analysis with forecasts to 2050Shanshan Wang, Fei Xie, Shaowei Sang
International Journal of Antimicrobial Agents|September 10, 2026
Aztreonam-avibactam Activity against Enterobacterales from Asia Pacific and Latin American Medical Centres: Summary of 5 years of Surveillance prior to Clinical Use (2020-2024)Helio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Pageof 613